VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-00949
Package ID: USCOURTS-cofc-1_18-vv-00949
Petitioner: Gregory Jackson
Filed: 2018-07-02
Decided: 2022-10-05
Vaccine: Tdap
Vaccination date: 2017-05-18
Condition: Guillain-Barré Syndrome (GBS)
Outcome: compensated
Award amount USD: 160000

AI-assisted case summary:
Gregory Jackson filed a petition on July 2, 2018, alleging that he suffered Guillain-Barré Syndrome (GBS) as a result of a tetanus-diphtheria-acellular pertussis (Tdap) vaccine he received on May 18, 2017. The respondent denied that the vaccine caused Petitioner's alleged GBS or any other injury, and denied that his current condition was a sequela of a vaccine-related injury. The parties reached a stipulation recommending an award of compensation. Special Master Nora Beth Dorsey adopted the stipulation as the decision of the Court. The stipulation provided for compensation in the amount of $160,000.00 in the form of a check payable to Petitioner, representing all damages available under 42 U.S.C. § 300aa-15(a). The parties agreed to waive their right to seek review, and judgment was entered accordingly. The public decision does not describe the onset of symptoms, specific medical tests, treatments, or expert witnesses. Petitioner's counsel was Renee Ja Gentry, and respondent's counsel was Ronalda Elnetta Kosh.

Theory of causation field:
Petitioner Gregory Jackson alleged that a Tdap vaccine received on May 18, 2017, caused Guillain-Barré Syndrome (GBS). The respondent denied causation. The parties reached a stipulation for compensation, which was adopted by Special Master Nora Beth Dorsey. The stipulation awarded Petitioner $160,000.00 for all damages. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury. The case was resolved via stipulation, with judgment entered upon waiver of the right to seek review.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_18-vv-00949-0
Date issued/filed: 2022-10-31
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 10/5/2022) regarding 85 DECISION Stipulation. Signed by Special Master Nora Beth Dorsey. (kis) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-00949-UNJ Document 89 Filed 10/31/22 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
Filed: October 5, 2022
* * * * * * * * * * * * * * * * * * *
GREGORY JACKSON, * UNPUBLISHED
*
Petitioner, * No. 18-949V
*
v. * Special Master Dorsey
*
SECRETARY OF HEALTH * Decision Based on Stipulation; Tetanus-
AND HUMAN SERVICES, * Diphtheria-Acellular Pertussis (“Tdap”)
* Vaccine; Guillain-Barré Syndrome (“GBS”).
Respondent. *
*
* * * * * * * * * * * * * * * * * * *
Renee Ja Gentry, The Law Office of Renee J. Gentry, Washington, DC, for Petitioner.
Ronalda Elnetta Kosh, U.S. Department of Justice, Washington, DC, for Respondent.
DECISION BASED ON STIPULATION1
On July 2, 2018, Gregory Jackson (“Petitioner”) filed a petition in the National Vaccine
Injury Program2 alleging that he suffered Guillain-Barré Syndrome (“GBS”) as a result of a
tetanus-diphtheria-acellular pertussis (“Tdap”) vaccine he received on May 18, 2017. Petition at
1-2 (ECF No. 1).
On October 5, 2022, the parties filed a stipulation recommending an award of
compensation to Petitioner. Stipulation (ECF No. 84). Respondent denies that the Tdap vaccine
caused Petitioner’s alleged GBS, or any other injury; and denies that his current condition is a
1 Because this Decision contains a reasoned explanation for the action in this case, the
undersigned is required to post it on the United States Court of Federal Claims’ website in
accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal
Management and Promotion of Electronic Government Services). This means the Decision will
be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b),
Petitioner has 14 days to identify and move to redact medical or other information, the disclosure
of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned
agrees that the identified material fits within this definition, the undersigned will redact such
material from public access.
2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National
Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended,
42 U.S.C. §§ 300aa-10 to -34 (2012) (“Vaccine Act” or “the Act”). All citations in this Decision
to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa.
1

Case 1:18-vv-00949-UNJ Document 89 Filed 10/31/22 Page 2 of 7
sequelae of a vaccine-related injury. Nevertheless, the parties agree to the joint stipulation,
attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as
the decision of the Court in awarding damages, on the terms set forth therein.
The parties stipulate that Petitioner shall receive the following compensation:
(1) A lump sum of $160,000.00 in the form of a check payable to Petitioner.
This amount represents compensation for all damages that would be available under 42
U.S.C. § 300aa-15(a). Stipulation at ¶ 8.
The undersigned approves the requested amount for Petitioner’s compensation.
Accordingly, an award should be made consistent with the stipulation.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of
Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3
IT IS SO ORDERED.
s/Nora B. Dorsey
Nora B. Dorsey
Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of
notice renouncing the right to seek review.
2

Case 1:18-vv-00949-UNJ Document 89 Filed 10/31/22 Page 3 of 7

Case 1:18-vv-00949-UNJ Document 89 Filed 10/31/22 Page 4 of 7

Case 1:18-vv-00949-UNJ Document 89 Filed 10/31/22 Page 5 of 7

Case 1:18-vv-00949-UNJ Document 89 Filed 10/31/22 Page 6 of 7

Case 1:18-vv-00949-UNJ Document 89 Filed 10/31/22 Page 7 of 7